Development and clinical application of a symptom cluster intervention model in the perioperative period in patients with non small cell lung cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200064361

Enrollment

Unknown

Registered

2022-10-04

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

intervention group:Non-pharmacological interventions

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with pathologically diagnosed primary NSCLC, to be admitted for anatomical lobectomy; age = 18 years; clear diagnosis of their own condition and cancer; with some understanding and verbal ability and consent to participate in this study.

Exclusion criteria

Exclusion criteria: Those with pre-existing or current mental illness and impaired consciousness; those with comorbid other malignancies or other serious life-threatening diseases; KPS scores = 60; and those receiving preoperative neoadjuvant radiotherapy or immunotherapy.

Design outcomes

Primary

Measure	Time frame
symptom;	—

Secondary

Measure	Time frame
inflammatory cytokines;physical function;quality of life;	—

Countries

China

Contacts

Public ContactJingfang Hong

Anhui Medical University

hongjingfang@ahmu.edu.cn+86 15955179337

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026